SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales is pegged at Rs. 51366.00 millions for the June 2026 quarter. The mentioned figure indicates a decline of about -34.23% as against Rs. 78095.00 millions during the year-ago period.A radical decline of -86.33% was reported in the net profit of the company for the quarter ended June 2026 to Rs. 4047.00  millions from Rs. 29612.00 millions.The company reported a degrowth in operating Profit to 8878.00 millions from 42353.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 51366.00 78095.00 -34.23 51366.00 78095.00 -34.23 205328.00 231154.00 -11.17
Other Income 4404.00 3983.00 10.57 4404.00 3983.00 10.57 16896.00 10034.00 68.39
PBIDT 8878.00 42353.00 -79.04 8878.00 42353.00 -79.04 56070.00 83852.00 -33.13
Interest 731.00 192.00 280.73 731.00 192.00 280.73 1483.00 1099.00 34.94
PBDT 8147.00 42161.00 -80.68 8147.00 42161.00 -80.68 54587.00 82753.00 -34.04
Depreciation 3177.00 2798.00 13.55 3177.00 2798.00 13.55 12074.00 10394.00 16.16
PBT 4970.00 39363.00 -87.37 4970.00 39363.00 -87.37 42513.00 72359.00 -41.25
TAX 923.00 9751.00 -90.53 923.00 9751.00 -90.53 10316.00 18865.00 -45.32
Deferred Tax 422.00 334.00 26.35 422.00 334.00 26.35 1139.00 960.00 18.65
PAT 4047.00 29612.00 -86.33 4047.00 29612.00 -86.33 32197.00 53494.00 -39.81
Equity 835.00 835.00 0.00 835.00 835.00 0.00 835.00 834.00 0.12
PBIDTM(%) 17.28 54.23 -68.13 17.28 54.23 -68.13 27.31 36.28 -24.72

Dr. Reddys Labs. Share Price

1145.65 -5.25 (-0.46%)
28-Jul-2026 10:45 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1986.60
Dr. Reddys Labs. 1145.65
Cipla 1432.90
Lupin 2406.00
Zydus Lifesciences 1110.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: